Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis | JACC: Heart Failure
The PARADIGM-HF trial (reproduced with permission from Wolters Kluwer). 6 | Download Table
PARADIGM-HF and PARAGON-HF: Redefining HFrEF and HFpEF - PACE-CME
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial - Bhatt - 2021 - European Journal of Heart Failure - Wiley Online Library
Entrestro for HFrEF: Are there any controversies?
Clinical Trial and Biomarker Data | ENTRESTO® (sacubitril/valsartan) | HCP
Clinical Trial and Biomarker Data | ENTRESTO® (sacubitril/valsartan) | HCP
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure | Circulation
CardsJC: PARAGON-HF Trial Journal Club - Cardionerds
Entresto Use in Heart Failure w Preserved Function – The Early Career Voice
Frontiers | Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum
Emerging Mechanisms in the Management of Heart Failure With Reduced Ejection Fraction
Emerging Mechanisms in the Management of Heart Failure With Reduced Ejection Fraction
Neprilysin: Indications, Expectations, and Challenges | Revista Española de Cardiología
Clinical Trial and Biomarker Data | ENTRESTO® (sacubitril/valsartan) | HCP
Critical Questions about PARADIGM-HF and the Future
Understanding the early mortality benefit observed in the PARADIGM-HF | VHRM
![PDF] Critical Questions about PARADIGM-HF and the Future. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/918ced0a75a7d84e5e8997682bb61d92ebedf17a/4-Figure2-1.png "PDF] Critical Questions about PARADIGM-HF and the Future. | Semantic Scholar")
PDF] Critical Questions about PARADIGM-HF and the Future. | Semantic Scholar
PARADISE MI Trial: Is Sacubitril/valsartan (Entresto) useful in patients with acute MI? – Visualmed
New heart failure agent doubles mortality benefit of ACE inhibitors - PACE-CME
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF - ScienceDirect
Historical timeline of breakthrough clinical trials for heart failure... | Download Scientific Diagram
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure | NEJM
Industry Sponsored Trials and Entresto in CHF - REBEL EM - Emergency Medicine Blog
Understanding the early mortality benefit observed in the PARADIGM-HF | VHRM
PARADIGM-HF: A Concise Summary with Journal Club Questions - YouTube
Update on PARADIGM-HF Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial John J.V. - ppt video online download
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure | NEJM
